Focus: Caladan Therapeutics is a Brooklyn-based biotechnology company specializing in bioreactor systems for ophthalmology applications. The company operates as a pre-revenue biotech with limited public disclosure of scale or market position.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Stable — net -4 jobs in 30d
1 added, 5 removed. Backfill posture.
Caladan presents a high-risk, potentially high-reward early-stage opportunity best suited for career builders willing to invest in an unproven platform during company formation.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Caladan Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Caladan Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo